As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...
Google CEO Sunder Pichai recently stated that “in the future almost everything will be done in the cloud as there will be no better way of doing things.” Believe it or not, in this day and age when ...
GlobalData on MSN
FDA protocol deviation guidance could go further
Protocol deviations can be extremely costly to clinical trials - both financially and with patient safety. In some cases, ...
The vast potential of decentralized finance (DeFi) is frequently overshadowed by the risks associated with crypto markets and decentralized platforms. The lack of reliable insurance policies leads to ...
WASHINGTON, March 19, 2017 (GLOBE NEWSWIRE) -- Data from Abiomed’s (NASDAQ:ABMD) Impella ® Quality (IQ) Assurance Program, which includes the IQ Database and cVAD Registry, was presented today as late ...
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow. Try it Now Aptos Labs Co-Founder & CEO Mo Shaikh joins Jill Malandrino on Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback